Larvol Delta - Viracta-Therapeutics-Reports-Third-Quarter-2021-Financial-Results-and-Provides-Corporate-Update

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

vecabrutinib (SNS-062) - Viracta Therap

nanatinostat (VRx-3996) - Viracta Therap

https://www.prnewswire.com/news-releases/viracta-therapeutics-reports-third-quarter-2021-financial-results-and-provides-corporate-update-301421020.html

Nov 10, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next